Hanmi Pharm. Co., Ltd. (KRX:128940)
279,500
0.00 (0.00%)
At close: Jul 31, 2025, 3:30 PM KST
United States Steel Market Cap
Hanmi Pharm. has a market cap or net worth of 3.42 trillion as of August 1, 2025. Its market cap has decreased by -3.05% in one year.
Market Cap
3.42T
Enterprise Value
3.83T
Revenue
1.48T
Ranking
n/a
PE Ratio
31.43
Stock Price
$279,500.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 3.42T, an increase of 402.96%. That is a compound annual growth rate of 11.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 3,423.66B | -3.74% |
Dec 30, 2024 | 3,556.80B | -20.49% |
Dec 28, 2023 | 4,473.42B | 20.54% |
Dec 29, 2022 | 3,711.17B | 10.00% |
Dec 30, 2021 | 3,373.87B | -23.27% |
Dec 30, 2020 | 4,397.24B | 25.97% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.59T |
Celltrion | 37.76T |
ALTEOGEN | 22.55T |
Yuhan | 8,432.74B |
SK Biopharmaceuticals | 7,345.78B |
Peptron | 6,523.26B |
HLB Co., Ltd. | 6,040.81B |
PharmaResearch | 5,724.70B |